α-helical structure in the C-terminus of vasoactive intestinal peptide: functional and structural consequencesONOUE, Satomi; MATSUMOTO, Asami; NAGANO, Yumiko et al.European journal of pharmacology. 2004, Vol 485, Num 1-3, pp 307-316, issn 0014-2999, 10 p.Article

Regulation of TLR expression, a new perspective for the role of VIP in immunityGOMARIZ, R. P; ARRANZ, A; JUARRANZ, Y et al.Peptides (New York, NY. 1980). 2007, Vol 28, Num 9, pp 1825-1832, issn 0196-9781, 8 p.Article

Separation of recombinant human vasoactive intestinal peptide-humanin fusion protein via three different approachesJING CHANG; JINCHUN CHEN.Biochemical engineering journal. 2008, Vol 41, Num 2, pp 116-121, issn 1369-703X, 6 p.Article

Vasoactive intestinal peptide enhances wound healing and proliferation of human bronchial epithelial cellsGUAN, Cha-Xiang; MIN ZHANG; QIN, Xiao-Qun et al.Peptides (New York, NY. 1980). 2006, Vol 27, Num 12, pp 3107-3114, issn 0196-9781, 8 p.Article

Role of Vasoactive Intestinal Peptide in Hyperoxia-Induced Injury of Primary Type II Alveolar Epithelial CellsXIAOXIAO AO; FANG FANG; FENG XU et al.Indian journal of pediatrics. 2011, Vol 78, Num 5, pp 535-539, issn 0019-5456, 5 p.Article

Identification and optimization of small molecule antagonists of vasoactive intestinal peptide receptor-1 (VIPER1)HARIKRISHNAN, Lalgudi S; SRIVASTAVA, Neelam; BURFORD, Neil T et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 6, pp 2287-2290, issn 0960-894X, 4 p.Article

Clustering of selectivity for optic flow in the ventral intraparietal areaTAO ZHANG; BRITTEN, Kenneth H.Neuroreport (Oxford). 2004, Vol 15, Num 12, pp 1941-1945, issn 0959-4965, 5 p.Article

Complex array of cytokines released by vasoactive intestinal peptideBRENNEMAN, Douglas E; PHILLIPS, Terry M; HAUSER, Janet et al.Neuropeptides (Edinburgh). 2003, Vol 37, Num 2, pp 111-119, issn 0143-4179, 9 p.Article

From galactorrhea to osteopenia: Rethinking serotonin-prolactin interactionsEMILIANO, Ana B. F; FUDGE, Julie L.Neuropsychopharmacology (New York, NY). 2004, Vol 29, Num 5, pp 833-846, issn 0893-133X, 14 p.Article

Vagal postganglionic origin of vasoactive intestinal polypeptide (VIP) mediating the vagal tachycardiaMARKOS, F; SNOW, H. M.European journal of applied physiology. 2006, Vol 98, Num 4, pp 419-422, 4 p.Article

6th International Symposium on VIP, PACAP and Related PeptidesSHIODA, Seiji.Regulatory peptides. 2004, Vol 123, Num 1-3, issn 0167-0115, 254 p.Conference Proceedings

Role of nerve growth factor in the regulation of parotid cell differentiation induced by rat serumTAKEUCHI, Takashi; ALETTA, John M; LAYCHOCK, Suzanne G et al.Biochemical pharmacology. 2003, Vol 65, Num 9, pp 1507-1513, issn 0006-2952, 7 p.Article

Etude Immunopharmacologique In vitro du Calcitonin Gene-Related Peptide I (CGRP I) et du Vasoactive Intestinal Peptide (VIP) chez la souris BALB/c = In Vitro, Immunopharmacological Study of Calcitonin Gene-Related Peptide I (CGRP I) and Vasoactive Intestinal Peptide (VIP) in BALB/c MiceBoudard, Frédéric; Bastide, Madeleine.1992, 185 p.Thesis

Neurotransmitters co-existing with VIP or PACAPFAHRENKRUG, Jan; HANNIBAL, Jens.Peptides (New York, NY. 1980). 2004, Vol 25, Num 3, pp 393-401, issn 0196-9781, 9 p.Article

VPAC receptor mediated tumor cell targeting by protamine based nanoparticlesORTNER, Anna; WERNIG, Karin; KAISLER, Raphaela et al.Journal of drug targeting. 2010, Vol 18, Num 6, pp 457-467, issn 1061-186X, 11 p.Article

Differential involvement of hippocampal vasoactive intestinal peptide in nociception of rats with a model of depressionBELCHEVA, Iren; IVANOVA, Margarita; TASHEV, Roman et al.Peptides (New York, NY. 1980). 2009, Vol 30, Num 8, pp 1497-1501, issn 0196-9781, 5 p.Article

Plasma neuropeptides and perception of pruritus in psoriasisREICH, Adam; ORDA, Alina; WISNICKA, Beata et al.Acta dermato-venereologica. 2007, Vol 87, Num 4, pp 299-304, issn 0001-5555, 6 p.Article

Intracellular signaling molecules involved in vasoactive intestinal peptide-mediated wound healing in human bronchial epithelial cellsCHA XIANG GUAN; YAN RU CUI; MIN ZHANG et al.Peptides (New York, NY. 1980). 2007, Vol 28, Num 9, pp 1667-1673, issn 0196-9781, 7 p.Article

Vasoactive intestinal peptide protects alveolar epithelial cells against hyperoxia via promoting the activation of STAT3XIAOXIAO AO; FANG FANG; FENG XU et al.Regulatory peptides. 2011, Vol 168, Num 1-3, pp 1-4, issn 0167-0115, 4 p.Article

Vasoactive intestinal peptide re-balances TREM-1/TREM-2 ratio in acute lung injurySUN, Guo-Ying; GUAN, Cha-Xiang; YONG ZHOU et al.Regulatory peptides. 2011, Vol 167, Num 1, pp 56-64, issn 0167-0115, 9 p.Article

Effect of vasoactive intestinal peptide on gastric adenocarcinomaLI, Guo-Hua; WEI QIAN; SONG, Geng-Qing et al.Journal of gastroenterology and hepatology. 2007, Vol 22, Num 8, pp 1328-1335, issn 0815-9319, 8 p.Article

Plasma concentration of selected neuropeptides in patients suffering from psoriasisREICH, Adam; ORDA, Alina; WISNICKA, Beata et al.Experimental dermatology. 2007, Vol 16, Num 5, pp 421-428, issn 0906-6705, 8 p.Article

Substance P and vasoactive intestinal peptide in rat small-bowel isograftsTOMITA, Ryouichi; FUJISAKI, Shigeru; PARK, Eichi et al.The American journal of surgery. 2005, Vol 189, Num 1, pp 63-70, issn 0002-9610, 8 p.Article

Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus mazeALCALAY, Roy N; GILADI, Eliezer; PICK, Chaim G et al.Neuroscience letters. 2004, Vol 361, Num 1-3, pp 128-131, issn 0304-3940, 4 p.Article

Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitisMIOTTO, D; BOSCHETTO, P; BONONI, I et al.The European respiratory journal. 2004, Vol 24, Num 6, pp 958-963, issn 0903-1936, 6 p.Article